Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides

AIDS

Volumn 16, Issue 2, 2002, Pages 245-249

  Barreiro, Pablo ^a   Soriano, Vincent ^a,c   Casas, Esperanza ^b   González Lahoz, Juan ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c NONE   (Spain)

Author keywords

Antiretroviral therapy; CD4 cell count; Immune response; Non nucleoside reverse transcriptase inhibitors; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; INDINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; NUCLEOSIDES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 0037169169     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200201250-00014     Document Type: Article

References (31)

1. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, HIV-seropositive patients: Independence of CD4+ cell numbers and clinical staging
2. CD8 naive T cell counts decrease progressively in HIV infected adults
3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
4. Viral dynamics in human immunodeficiency virus type 1 infection
5. Evolution and plasticity of CTL responses against HIV
6. Programmed death of T cells in HIV-1 infection
7. Activation-induced death by apoptosis in CD4+ T cells from HIV-infected asymptomatic individuals
8. Apoptosis in AIDS
9. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsilar tissue in asymptomatic HIV-1 infection
10. HIV induces thymus depletion in vivo
11. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
12. The enlarged lymph nodes of HIV-1 infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy
13. Kinetics of response in lymphoid tissue to antiretroviral therapy of HIV-1 infection
14. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
15. Host factors and the pathogenesis of HIV-induced disease
16. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA
17. Activation and cell cycle antigens in CD4+ and CB8+ T cells correlate with plasma HIV-1 RNA level in HIV-1 infection
18. Immune function and phenotype before and after highly active antiretroviral therapy
19. Long lasting recovery in CD4+ T cell function mirrors viral load reduction after highly active antiretroviral therapy in patients with advanced HIV disease
20. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2
21. Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy
22. A randomized, double-blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV-infected patients. The INCAS trial
23. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
24. Decreased HIV-associated T cell apoptosis by HIV protease inhibitors
25. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society-USA Panel
26. Cellular restoration in HIV-infected persons treated with abacavir and a protease inhibitor: Age inversely predicts naive CD4 cell count increase
27. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
28. A randomized, open, multicenter trial comparing combivir plus nelfinavir or nevirapine in HIV-infected naive patients (The Combine Study)
29. ACTG 364-nelfinavir and/or efavirenz in combination with new NRTIs in nucleoside experienced subjects: Week 48 ultrasensitive HIV RNA results
30. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
31. Higher antiviral activity of antiretroviral regimens including protease inhibitors